Spruce Biosciences, Inc. SEC filings SPRB
Spruce Biosciences, Inc. has 366 filings in SEC EDGAR's recent list, going back to Feb 28, 2020. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 22, 2026 | Apr 20, 2026 |
| 424B5 | Prospectus supplement | Apr 21, 2026 | — |
| 424B5 | Prospectus supplement | Apr 20, 2026 | — |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 20, 2026 | Mar 16, 2026 |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Officer or director change
|
Mar 9, 2026 | Mar 9, 2026 |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 11, 2025 |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2025 | Dec 11, 2025 |
| EFFECT | Filing | Nov 26, 2025 | — |
| EFFECT | Filing | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| S-3 | Shelf registration | Oct 29, 2025 | — |
| S-3 | Shelf registration | Oct 29, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2025 | Oct 15, 2025 |
| D | Filing | Oct 17, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 8, 2025 | Oct 7, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 12, 2025 | Jun 9, 2025 |
| DEFA14A | Additional proxy material | Jun 12, 2025 | — |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 29, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Listing notice
|
Apr 25, 2025 | Apr 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 9, 2025 |
| S-8 | Employee stock plan registration | Apr 15, 2025 | — |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2025 | Mar 31, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 28, 2024 | Oct 24, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 22, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 30, 2024 | Apr 26, 2024 |
| ARS | Annual report to shareholders | Apr 5, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | May 22, 2024 |
| S-8 | Employee stock plan registration | Mar 18, 2024 | — |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Mar 13, 2024 | Mar 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 4, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Officer or director change
|
May 25, 2023 | May 22, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| EFFECT | Filing | Apr 7, 2023 | — |
| CORRESP | Letter to the SEC | Apr 5, 2023 | — |
| ARS | Annual report to shareholders | Apr 5, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 5, 2023 | May 25, 2023 |
| UPLOAD | Letter from the SEC | Mar 21, 2023 | — |
| S-3 | Shelf registration | Mar 16, 2023 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| D | Filing | Feb 28, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 9, 2023 | Feb 8, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 9, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 2, 2022 | Nov 28, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2022 | May 25, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 6, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 25, 2022 |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| 8-K |
Current report
Other events
|
Mar 14, 2022 | Mar 14, 2022 |
| 10-K | Annual report | Mar 14, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2022 | Mar 14, 2022 |
| 424B5 | Prospectus supplement | Feb 28, 2022 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| S-3/A | Filing | Feb 9, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2022 | — |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Jan 5, 2022 | Dec 29, 2021 |
| S-3 | Shelf registration | Dec 30, 2021 | — |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 25, 2021 | Aug 25, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2021 | May 20, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Apr 2, 2021 | — |
| DEF 14A | Proxy statement | Apr 2, 2021 | May 20, 2021 |
| S-8 | Employee stock plan registration | Mar 22, 2021 | — |
| 10-K | Annual report | Mar 22, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2021 | Jan 6, 2021 |
| 10-Q | Quarterly report | Nov 18, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 14, 2020 | Oct 14, 2020 |
| S-8 | Employee stock plan registration | Oct 9, 2020 | — |
| 424B4 | Prospectus | Oct 9, 2020 | — |
| EFFECT | Filing | Oct 8, 2020 | — |
| S-1MEF | Filing | Oct 8, 2020 | — |
| CORRESP | Letter to the SEC | Oct 6, 2020 | — |
| CORRESP | Letter to the SEC | Oct 6, 2020 | — |
| CERT | Filing | Oct 6, 2020 | — |
| 8-A12B | Filing | Oct 5, 2020 | — |
| S-1/A | Amended registration statement | Oct 5, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 2, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| S-1 | Registration statement | Sep 18, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2020 | — |
| D/A | Filing | Aug 14, 2020 | — |
| DRS | Filing | Aug 7, 2020 | — |
| D | Filing | Feb 28, 2020 | — |
Showing 155 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1683553
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.